Ligand Pharmaceuticals (NASDAQ:LGND) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Ligand Pharmaceuticals beat estimated earnings by 31.39%, reporting an EPS of $1.8 versus an estimate of $1.37.
Revenue was up $2.48 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.54, which was followed by a 9.2% increase in the share price the next day.
Here's a look at Ligand Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 1.04 | 1.34 | 1.12 | 0.99 |
| EPS Actual | 1.58 | 1.63 | 1.41 | 1.62 |
| Revenue Estimate | 55.65M | 70.41M | 62.85M | 54.09M |
| Revenue Actual | 64.83M | 84.67M | 55.15M | 69.99M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
